We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.85%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$260B
AUM Growth
+$17.6B
Cap. Flow
+$9.95B
Cap. Flow %
3.83%
Top 10 Hldgs %
14.4%
Holding
8,581
New
810
Increased
3,919
Reduced
2,793
Closed
626

Sector Composition

Rank Sector Weight
1 Technology 9.74%
2 Financials 7.41%
3 Healthcare 6.49%
4 Consumer Discretionary 5.87%
5 Industrials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLNT
7751
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$1K ﹤0.01%
210
RWGE
7752
DELISTED
Regalwood Global Energy Ltd. Class A Ordinary Shares
RWGE
$1K ﹤0.01%
100
COMG
7753
DELISTED
GraniteShares S&P GSCI Commodity Broad Strategy No K-1 ETF
COMG
$1K ﹤0.01%
47
-162
-78% -$3.6K
IPOA.WS
7754
DELISTED
Social Capital Hedosophia Holdings Corp. Warrants, each whole warrant exercisable for one Class A Or
IPOA.WS
$1K ﹤0.01%
916
-1,984
-68% -$1.92K
AAC
7755
DELISTED
AAC Holdings
AAC
$1K ﹤0.01%
850
-1,154
-58% -$1.62K
NVLN
7756
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$1K ﹤0.01%
1,666
-4,482
-73% -$4.99K
EMMA
7757
DELISTED
Emmaus Life Sciences, Inc. Common Stock
EMMA
$1K ﹤0.01%
191
-380
-67% -$2.82K
CNACR
7758
DELISTED
Constellation Alpha Capital Corp. Right
CNACR
$1K ﹤0.01%
4,200
+300
+8% +$56
CNACW
7759
DELISTED
Constellation Alpha Capital Corp. Warrant
CNACW
$1K ﹤0.01%
10,500
+100
+1% +$7
ADOM
7760
DELISTED
ADOMANI Inc
ADOM
$1K ﹤0.01%
3,251
-666
-17% -$225
DYNC
7761
DELISTED
Vistra Energy Corp.
DYNC
$1K ﹤0.01%
+10
New +$984
SLNOW
7762
DELISTED
Soleno Therapeutics, Inc. Series A Warrant
SLNOW
$1K ﹤0.01%
5,523
OSN
7763
DELISTED
Ossen Innovation Co., Ltd.
OSN
$1K ﹤0.01%
748
-236
-24% -$465
ARC
7764
DELISTED
ARC Document Solutions, Inc.
ARC
$1K ﹤0.01%
301
-6,657
-96% -$14.6K
KGJI
7765
DELISTED
Kingold Jewelry Inc.
KGJI
$1K ﹤0.01%
242
-757
-76% -$3.54K
HAUD
7766
DELISTED
iShares Currency Hedged MSCI Australia ETF
HAUD
$1K ﹤0.01%
50
VVUS
7767
DELISTED
Vivus Inc
VVUS
$1K ﹤0.01%
165
-3,921
-96% -$14.4K
PNRL
7768
DELISTED
Paringa Resources Limited American Depositary Shares
PNRL
$1K ﹤0.01%
162
+30
+23% +$134
BIQI
7769
DELISTED
BIQI International Holdings Corporation Common Shares
BIQI
$1K ﹤0.01%
+989
New +$1.27K
TWLVW
7770
DELISTED
Twelve Seas Investment Company Warrant
TWLVW
$1K ﹤0.01%
5,700
-18,320
-76% -$4.62K
ABEV icon
7771
CALL
Ambev
ABEV
$48.1B
-320,700
Closed -$1.38M
ACHV icon
7772
Achieve Life Sciences
ACHV
$659M
0
ACU icon
7773
Acme United Corp
ACU
$217M
-2,881
Closed -$46K
ADM icon
7774
CALL
Archer Daniels Midland
ADM
$38.2B
-1,700
Closed -$73K
AEM icon
7775
CALL
Agnico Eagle Mines
AEM
$73.6B
-2,000
Closed -$87K

Similar funds

UBS Group's Q2 2019 Portfolio in Review

As of Q2 2019, UBS Group held 8,581 positions worth $260B, up 7.3% from $242B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group deployed $9.95B of net new capital in Q2 2019, opening 810 new positions and adding to 3,919 existing holdings. Its largest new stake was Dow Inc: 4,472,376 shares worth $221M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $377M trimmed.

  • UBS Group's largest Q2 2019 buy was Dow Inc: 4,472,376 shares worth $221M.
  • UBS Group added most to UBS Group in Q2 2019, an estimated $1.59B increase.
  • UBS Group's biggest Q2 2019 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $377M.
  • UBS Group fully exited Bemis in Q2 2019, selling an estimated $102M.
  • UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q2 2019.
  • UBS Group opened 810 new positions and closed 626 in Q2 2019.
  • UBS Group's portfolio value rose 7.3% quarter-over-quarter to $260B.

Based on UBS Group's 13F filing for Q2 2019, filed 14 Aug 2019.